Trials / Recruiting
RecruitingNCT05392881
Interstitial Lung Disease Research Unit Biobank
University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
Detailed description
The University of Kansas ILD and Rare Lung Disease clinic sees hundreds of new patients per year. The investigators would like to leverage this resource to develop an Interstitial Lung Disease Research Unit (ILDRU) repository and database to help develop new methods for early diagnosis, uncover underlying genetic and environmental risk factors, as well as potential treatment targets in the broad range of interstitial lung diseases and rare lung diseases (RLD).
Conditions
- Interstitial Lung Disease
- Sarcoidosis
- Idiopathic Pulmonary Fibrosis
- Pulmonary Fibrosis
- Hypersensitivity Pneumonitis
Timeline
- Start date
- 2021-08-09
- Primary completion
- 2031-08-01
- Completion
- 2032-03-01
- First posted
- 2022-05-26
- Last updated
- 2025-09-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05392881. Inclusion in this directory is not an endorsement.